ANGLE plc (ANGLE) is a holding commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company�s principal subsidiaries are Parsortix Inc (Parsortix) and Novocellus Limited, which are commercially driven specialist medical diagnostics companies with pioneering products in cancer diagnostics and foetal health. ANGLE also owns a major investment in Geomerics Limited, a business with a computer graphics technology platform, and a specialist technology consultancy. The Company operates in four segments: Controlled investments in medical diagnostics, Non-controlled investments, Ventures and Management services. ANGLE has developed its Parsortix technology to capture circulating tumor cells (CTCs) in cancer patient blood.